The NY Center for the Prevention of Heart Disease has announced its advanced cholesterol testing services through Boston Heart Diagnostic Labs, with a detailed lipid analysis to detect cardiovascular risk factors missed by traditional screening methods.
-- The NY Center for the Prevention of Heart Disease has introduced advanced cholesterol testing services through Boston Heart Diagnostic Labs. The testing provides a more detailed analysis of cardiovascular risk factors that routine screening does not capture, helping patients and physicians make more informed decisions about prevention.
More details can be found at https://www.thenyheartcenter.com
This announcement comes at a time when the limitations of standard cardiovascular screening can no longer be ignored. The new 2026 ACC/AHA Multisociety Cholesterol Guidlines emphasize earlier, more aggressive cholesterol management to lower lifelong cardiovascular risk. According to the American Heart Association, a significant proportion of heart attack patients have cholesterol levels that fall within the standard ‘normal’ range on routine tests. This means many individuals who receive reassuring cholesterol test results may actually still be at significant cardiovascular risk. This fact, combined with the fact that over 60% of patients having a heart attack had no prior symptoms, makes it essential to identify those at cardiovascular risk before they have a heart attack.
The NY Center for the Prevention of Heart Disease has developed its advanced cholesterol testing services to address this gap, identifying those who are at significant risk. Apo B , LDL-Particle number, small Dense LDL, Lpa, cardiometabolic markers, inflammatory cardiac markers and genetic markers for cardiovascular disease are all part of the advanced cholesterol profile offered at The NY Center for The Prevention of Heart Disease.
"The center provides patients with a detailed breakdown of cholesterol profiles. Unlike traditional methods that measure only total cholesterol and basic LDL levels, this Advanced Lipid Analysis identifies the specific types of LDL particles present, which research has indicated may provide greater predictive value for cardiovascular risk than standard cholesterol measures alone," says a spokesperson for Dr. Bradley Radwaner, the founder and medical director of the NY Center for the Prevention of Heart Disease. "By examining these important details, our medical team can develop personalized risk assessments and prevention strategies tailored to each patient's unique lipid profile."
Beyond cholesterol testing, the center integrates Coronary CT Angiography with Cleerly AI imaging and HeartFlow Analysis to identify coronary artery abnormalities that traditional stress testing frequently misses. The team notes that many of these plaques are non-obstructive and do not cause symptoms, making them difficult to detect with traditional stress tests.
Dr. Radwaner leads the center, which has focused on preventive cardiology for over 30 years, combining advanced diagnostics with personalized prevention protocols. The facility serves patients throughout New York, Westchester, Long Island, and New Jersey.
Individuals interested in learning more about the advanced cholesterol testing may visit https://www.thenyheartcenter.com/
Contact Info:
Name: Dr Radwaner
Email: Send Email
Organization: The NY Center for the Prevention of Heart Disease
Address: 136 East 57th Street, Suite 1001 Suite 1001, New York, NY 10022, United States
Website: https://www.thenyheartcenter.com/
Source: PressCable
Release ID: 89192490
If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.
